Dia Roy

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Regulatory T Cells

Top Venues

Science immunology

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Subhadip Pati, Sumon Mukherjee, Saikat Dutta, Aharna Guin, Dia Roy, Sayantan Bose, Silpita Paul, Sudipto Saha, Sankar Bhattacharyya, Pratyush Datta, Jayati Chakraborty, Diptendra K Sarkar, Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses. Cancer immunology research 11 (3) (2023)
Subhadip Pati, Sumon Mukherjee, Saikat Dutta, Aharna Guin, Dia Roy, Sayantan Bose, Silpita Paul, Sudipto Saha, Sankar Bhattacharyya, Pratyush Datta, Jayati Chakraborty, Diptendra K Sarkar, Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses. Cancer immunology research 11 (3) (2023)
Subhadip Pati, Sumon Mukherjee, Saikat Dutta, Aharna Guin, Dia Roy, Sayantan Bose, Silpita Paul, Sudipto Saha, Sankar Bhattacharyya, Pratyush Datta, Jayati Chakraborty, Diptendra K Sarkar, Gaurisankar Sa
Tumor-Associated CD19+CD39- B Regulatory Cells Deregulate Class-Switch Recombination to Suppress Antibody Responses. Cancer immunology research 11 (3) (2023)
Subhadip Pati, Sumon Mukherjee, Saikat Dutta, Aharna Guin, Dia Roy, Sayantan Bose, Silpita Paul, Sudipto Saha, Sankar Bhattacharyya, Pratyush Datta, Jayati Chakraborty, Diptendra K Sarkar, Gaurisankar Sa
Tumor-associated CD19+CD39- B regulatory cells deregulate class-switch recombination to suppress antibody responses. Cancer immunology research (2022)